Momenta Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
1:17-cv-00109
Overview
Parties
Defendant
Teva Pharmaceutical Industries Ltd. Operating Company
Represented By
4 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market St., 12th Floor, I. M. Pei Building
Teva Pharmaceuticals USA, Inc. Operating Company
Represented By
11 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market St., 12th Floor, I. M. Pei Building
Plaintiff
Teva Neuroscience, Inc. Operating Company
Represented By
4 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market St., 12th Floor, I. M. Pei Building
Momenta Pharmaceuticals, Inc. Operating Company
Represented By
8 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 25 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇨🇦 Canada | Canada Counterpart | View Official Patent → | |
| 🇰🇷 South Korea | South Korea Counterpart | View Official Patent → | |
| 🇰🇷 South Korea | South Korea Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇰🇷 South Korea | South Korea Counterpart | View Official Patent → | |
| 🇰🇷 South Korea | South Korea Counterpart | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9155775
Process for manufacturing glatiramer acetate product
|
Filed: 2015-01-28
Issued: 2015-10-13
|
Active (8.2 yrs remaining)
Expires: 2035-01-28
|
|
|
US9155755
Dietary supplements including glucan and fulvic acid
|
Filed: 2014-03-12
Issued: 2015-10-13
|
Active (7.3 yrs remaining)
Expires: 2034-03-12
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
22
Dispositive
1
Granted
0
Denied
0
Pending / Review
14
Motions by Category
Key Dispositive Motions & Rulings